AnPac Bio-Medical Science Co., Ltd. (ANPC): Price and Financial Metrics
AnPac Bio-Medical Science Co., Ltd. (ANPC)
Today's Latest Price: $6.20 USD
Updated Jan 19 3:41pm
Add ANPC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ANPC Stock Summary
- AnPac Bio-Medical Science Co Ltd's stock had its IPO on January 30, 2020, making it an older stock than just 0.18% of US equities in our set.
- ANPC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 4.3% of US stocks.
- AnPac Bio-Medical Science Co Ltd's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -94.37%, greater than the shareholder yield of only 3.22% of stocks in our set.
- Stocks that are quantitatively similar to ANPC, based on their financial statements, market capitalization, and price volatility, are DRIO, DHIL, GRIL, FN, and EMX.
- Visit ANPC's SEC page to see the company's official filings. To visit the company's web site, go to www.anpacbio.com.
ANPC Stock Price Chart Interactive Chart >
ANPC Price/Volume Stats
| Current price | $6.20 | 52-week high | $12.18 |
| Prev. close | $5.74 | 52-week low | $3.15 |
| Day low | $5.56 | Volume | 472,968 |
| Day high | $6.97 | Avg. volume | 88,208 |
| 50-day MA | $4.94 | Dividend yield | N/A |
| 200-day MA | $5.78 | Market Cap | 69.45M |
AnPac Bio-Medical Science Co., Ltd. (ANPC) Company Bio
Anpac Bio-Medical Science Co., Ltd., a development-stage biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China.
Loading social stream, please wait...